Teradyne Inc.

04/25/2024 | Press release | Distributed by Public on 04/25/2024 04:07

Teradyne Reports First Quarter 2024 Results - Form 8-K

Teradyne Reports First Quarter 2024 Results

Revenue and earnings above the high-end of Q1 guidance
Revenue of $600 million in Q1'24, down 3% from Q1'23
Strong year-over-year growth in memory test offset by continued softness in mobility

Q1'24

Q1'23

Q4'23

Revenue (mil)

$

600

$

618

$

671

GAAP EPS

$

0.40

$

0.50

$

0.72

Non-GAAP EPS

$

0.51

$

0.55

$

0.79

NORTH READING, Mass. - April 24, 2024 - Teradyne, Inc. (NASDAQ: TER) reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor Test, $75 million in System Test, $25 million in Wireless Test and $88 million in Robotics. GAAP net income for the first quarter was $64.2 million or $0.40 per diluted share. On a non-GAAP basis, Teradyne's net income in the first quarter was $82.5 million, or $0.51 per diluted share, which excluded stock compensation modification expense, acquired intangible asset amortization, restructuring and other charges, losses on foreign exchange options in connection with acquisitions and divestitures, and included the related tax impact on non-GAAP adjustments.

"Despite continued weakness in mobility, greater than expected memory and networking demand driven by Artificial Intelligence (AI) applications combined with Robotics shipments in-line with our expectations drove company revenue and earnings above the high end of our guidance in the quarter," said Teradyne CEO, Greg Smith. "Strength in memory and computing is driving stronger than expected performance in the first half of the year, however visibility beyond the second quarter remains limited. In Robotics, we expect new products, new applications and our global distribution channel improvements to fuel growth through the balance of the year."

Guidance for the second quarter of 2024 is revenue of $665 million to $725 million, with GAAP net income of $0.90 to $1.10 per diluted share and non-GAAP net income of $0.64 to $0.84 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization and a gain on the anticipated sale of Teradyne's Design Interface Solutions business to Technoprobe S.p.A. as well as the related tax impact on non-GAAP adjustments.

Webcast

A conference call to discuss the first quarter results, along with management's business outlook, will follow at 8:30 a.m. ET, Thursday, April 25, 2024. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 8:30 a.m. ET. A replay will be available on the Teradyne website at www.teradyne.com/investors.

Page 2

Non-GAAP Results

In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, restructuring and other, pension actuarial gains and losses, stock compensation modification expense, gains and losses on foreign exchange options in connection with acquisitions and divestitures, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne's baseline performance before gains, losses or other charges that may not be indicative of Teradyne's current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne's business plan, historical operating results and the operating results of Teradyne's competitors. Non-GAAP diluted shares include the impact of Teradyne's call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne's financial and operational performance, as well as facilitating meaningful comparisons of Teradyne's results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on "Investor Relations" and then selecting "Financials" and the "GAAP to Non-GAAP Reconciliation" link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.

About Teradyne

Teradyne (NASDAQ:TER) test technology helps bring high-quality innovations such as smart devices, life-saving medical equipment and data storage systems to market, faster. Its advanced test solutions for semiconductors, electronic systems, wireless devices and more ensure that products perform as they were designed. Its robotics offerings include collaborative and mobile robots that help manufacturers of all sizes increase productivity, improve safety, and lower costs. In 2023, Teradyne had revenue of $2.7 billion and today employs over 6,600 people worldwide. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.

Safe Harbor Statement

This release contains forward-looking statements including statements regarding Teradyne's future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "goal" or other comparable terms. Forward-looking statements in this press release address various matters, including statements regarding Teradyne's financial guidance. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements due to known and unknown risks, uncertainties, assumptions, and other factors. Such factors include, but are not limited to, macroeconomic factors and slowdowns or downturns in economic conditions generally and in the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; a slowdown or inability in the development, delivery and acceptance of new products; the ability to grow the Robotics business; the impact of increased research and development spending; the impact of epidemics or pandemics such as COVID-19; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in Teradyne's best interests; changes to U.S. or global tax regulations or guidance; the impact of any tariffs or export

Page 3

controls imposed by the U.S. or China; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the Israel-Hamas conflict; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China.

The risks included above are not exhaustive. For a more detailed description of the risk factors associated with Teradyne, please refer to Teradyne's Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Many of these factors are macroeconomic in nature and are, therefore, beyond Teradyne's control. We caution readers not to place undue reliance on any forward-looking statements included in this press release which speak only as to the date of this press release. Teradyne specifically disclaims any obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

Page 4

TERADYNE, INC. REPORT FOR FIRST FISCAL QUARTER OF 2024

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Quarter Ended

March 31,
2024

December 31,
2023

April 2,
2023

Net revenues

$

599,819

$

670,600

$

617,529

Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1)

260,537

291,055

261,109

Gross profit

339,282

379,545

356,420

Operating expenses:

Selling and administrative (2)

149,188

142,336

150,955

Engineering and development

103,199

102,207

105,762

Acquired intangible assets amortization

4,697

4,651

4,802

Restructuring and other (3)

4,427

6,027

2,037

Operating expenses

261,511

255,221

263,556

Income from operations

77,771

124,324

92,864

Interest and other (income) expense (4)

4,869

(15,482

)

(4,220

)

Income before income taxes

72,902

139,806

97,084

Income tax provision

8,705

22,752

13,553

Net income

$

64,197

$

117,054

$

83,531

Net income per common share:

Basic

$

0.42

$

0.77

$

0.54

Diluted

$

0.40

$

0.72

$

0.50

Weighted average common shares - basic

153,047

152,812

155,904

Weighted average common shares - diluted (5)

162,348

162,106

166,308

Cash dividend declared per common share

$

0.12

$

0.11

$

0.11

(1)
Cost of revenues includes:

Quarter Ended

March 31,
2024

December 31,
2023

April 2,
2023

Provision for excess and obsolete inventory

$

6,177

$

5,289

$

5,610

Sale of previously written down inventory

(722

)

(1,115

)

(385

)

$

5,455

$

4,174

$

5,225

(2)
For the quarter ended March 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne executives' retirement agreements. For the quarter ended April 2, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne's retired CEO's outstanding equity awards in connection with his February 1, 2023 retirement.
(3)
Restructuring and other consists of:

Quarter Ended

March 31,
2024

December 31,
2023

April 2,
2023

Acquisition and divestiture related expenses

$

2,214

$

3,132

-

Employee severance

2,026

2,892

2,037

Other

187

3

-

$

4,427

$

6,027

$

2,037

Page 5

(4)
Interest and other includes:

Quarter Ended

March 31,
2024

December 31,
2023

April 2,
2023

Loss (gain) on foreign exchange option

$

13,918

$

(7,464

)

$

-

Pension actuarial losses

-

2,575

-

(5)
Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarters ended December 31, 2023 and April 2, 2023, 0.2 million and 0.9 million shares, respectively, have been included in diluted shares. For the quarters ended March 31, 2024, December 31, 2023 and April 2, 2023, diluted shares also included 8.9 million, 8.6 million and 9.0 million shares, respectively, from the convertible note hedge transaction.

Page 6

CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)

March 31,
2024

December 31,
2023

Assets

Cash and cash equivalents

$

707,403

$

757,571

Marketable securities

41,300

62,154

Accounts receivable, net

426,333

422,124

Inventories, net

314,232

309,974

Prepayments

537,642

548,970

Other current assets

16,057

37,992

Current assets held for sale

22,426

23,250

Total current assets

2,065,393

2,162,035

Property, plant and equipment, net

457,248

445,492

Operating lease right-of-use assets, net

74,625

73,417

Marketable securities

121,905

117,434

Deferred tax assets

185,734

175,775

Retirement plans assets

11,449

11,504

Other assets

45,098

38,580

Acquired intangible assets, net

30,234

35,404

Goodwill

407,576

415,652

Assets held for sale

11,458

11,531

Total assets

$

3,410,720

$

3,486,824

Liabilities

Accounts payable

$

153,873

$

180,131

Accrued employees' compensation and withholdings

121,144

191,750

Deferred revenue and customer advances

96,419

99,804

Other accrued liabilities

101,275

114,712

Operating lease liabilities

17,400

17,522

Income taxes payable

55,922

48,653

Current liabilities held for sale

4,687

7,379

Total current liabilities

550,720

659,951

Retirement plans liabilities

134,878

132,090

Long-term deferred revenue and customer advances

38,683

37,282

Long-term other accrued liabilities

16,653

19,998

Deferred tax liabilities

134

183

Long-term operating lease liabilities

65,554

65,092

Long-term income taxes payable

44,331

44,331

Liabilities held for sale

1,938

2,000

Total liabilities

852,891

960,927

Shareholders' equity

2,557,829

2,525,897

Total liabilities and shareholders' equity

$

3,410,720

$

3,486,824

Page 7

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)

Quarter Ended

March 31,
2024

April 2,
2023

Cash flows from operating activities:

Net income

$

64,197

$

83,531

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

23,354

22,680

Stock-based compensation

15,758

18,885

Provision for excess and obsolete inventory

6,177

5,610

Amortization

4,766

4,926

Deferred taxes

(9,669

)

(7,634

)

Losses (gains) on investments

10,466

(2,238

)

Other

787

108

Changes in operating assets and liabilities

Accounts receivable

(8,055

)

37,204

Inventories

(6,932

)

(23,697

)

Prepayments and other assets

11,089

(15,380

)

Accounts payable and other liabilities

(105,548

)

(83,208

)

Deferred revenue and customer advances

(1,444

)

(32,705

)

Retirement plans contributions

(1,421

)

(1,234

)

Income taxes

3,754

12,488

Net cash provided by operating activities

7,279

19,336

Cash flows from investing activities:

Purchases of property, plant and equipment

(44,023

)

(41,444

)

Purchases of marketable securities

(16,042

)

(69,276

)

Proceeds from maturities of marketable securities

14,438

7,468

Proceeds from sales of marketable securities

20,734

7,929

Proceeds from life insurance

873

460

Net cash used for investing activities

(24,020

)

(94,863

)

Cash flows from financing activities:

Repurchase of common stock

(22,117

)

(93,308

)

Dividend payments

(18,370

)

(17,165

)

Payments of convertible debt principal

-

(15,155

)

Payments related to net settlement of employee stock compensation awards

(13,115

)

(19,870

)

Issuance of common stock under stock purchase and stock option plans

16,934

15,997

Net cash used for financing activities

(36,668

)

(129,501

)

Effects of exchange rate changes on cash and cash equivalents

3,241

(537

)

Decrease in cash and cash equivalents

(50,168

)

(205,565

)

Cash and cash equivalents at beginning of period

757,571

854,773

Cash and cash equivalents at end of period

$

707,403

$

649,208

Page 8

GAAP to Non-GAAP Earnings Reconciliation

(In millions, except per share amounts)

Quarter Ended

March 31,
2024

% of Net Revenues

December 31,
2023

% of Net Revenues

April 2,
2023

% of Net Revenues

Net revenues

$

599.8

$

670.6

$

617.5

Gross profit GAAP and non-GAAP

339.3

56.6

%

379.5

56.6

%

356.4

57.7

%

Income from operations - GAAP

77.8

13.0

%

124.3

18.5

%

92.9

15.0

%

Acquired intangible assets amortization

4.7

0.8

%

4.7

0.7

%

4.8

0.8

%

Restructuring and other (1)

4.4

0.7

%

6.0

0.9

%

2.0

0.3

%

Equity Modification Charge (4)

1.7

0.3

%

-

0.0

%

5.9

1.0

%

Income from operations - non-GAAP

$

88.6

14.8

%

$

135.0

20.1

%

$

105.6

17.1

%

Net Income
per Common Share

Net Income
per Common Share

Net Income
per Common Share

March 31,
2024

% of Net Revenues

Basic

Diluted

December 31,
2023

% of Net Revenues

Basic

Diluted

April 2,
2023

% of Net Revenues

Basic

Diluted

Net income - GAAP

$

64.2

10.7

%

$

0.42

$

0.40

$

117.1

17.5

%

$

0.77

$

0.72

$

83.5

13.5

%

$

0.54

$

0.50

Loss (gain) of foreign exchange option

13.9

2.3

%

0.09

0.09

(7.5

)

-1.1

%

(0.05

)

(0.05

)

-

-

-

-

Acquired intangible assets amortization

4.7

0.8

%

0.03

0.03

4.7

0.7

%

0.03

0.03

4.8

0.8

%

-

0.03

Restructuring and other (1)

4.4

0.7

%

0.03

0.03

6.0

0.9

%

0.04

0.04

2.0

0.3

%

0.01

0.01

Equity Modification Charge (4)

1.7

0.3

%

0.01

0.01

-

-

-

-

5.9

1.0

%

0.04

0.04

Pension mark-to-market adjustment (2)

-

-

-

-

2.6

0.4

%

0.02

0.02

-

-

-

-

Exclude discrete tax adjustments

(2.2

)

-0.4

%

(0.01

)

(0.01

)

3.3

0.5

%

0.02

0.02

(2.5

)

-0.4

%

(0.02

)

(0.02

)

Non-GAAP tax adjustments

(4.2

)

-0.7

%

(0.03

)

(0.03

)

1.0

0.1

%

0.01

0.01

(2.4

)

-0.4

%

(0.02

)

(0.01

)

Net income - non-GAAP

$

82.5

13.8

%

$

0.54

$

0.51

$

127.2

19.0

%

$

0.83

$

0.79

$

91.3

14.8

%

$

0.59

$

0.55

GAAP and non-GAAP weighted average common
shares - basic

153.0

152.8

155.9

GAAP weighted average common shares - diluted (3)

162.3

162.1

166.3

Exclude dilutive shares related to convertible note transaction

-

(0.2

)

(0.9

)

Non-GAAP weighted average common shares - diluted

162.3

161.9

165.4

(1)
Restructuring and other consists of:

Quarter Ended

March 31,
2024

December 31,
2023

April 2,
2023

Acquisition and divestiture related expenses

$

2.2

$

3.1

-

Employee severance

2.0

2.9

2.0

Other

0.2

-

-

$

4.4

$

6.0

$

2.0

(2)
For the quarter ended December 31, 2023, adjustment to exclude actuarial loss recognized under GAAP in accordance with Teradyne's mark-to-market pension accounting.

Page 9

(3)
For the quarters ended March 31, 2024, December 31, 2023, and April 2, 2023, non-GAAP weighted average diluted common shares include 8.9 million, 8.6 million and 9.0 million shares, respectively, from the convertible note hedge transaction.
(4)
For the quarter ended March 31, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne's executives' retirement agreements. For the quarter ended April 2, 2023, selling and administrative expenses included an equity charge of $5.9 million for the modification of Teradyne's retired CEO's outstanding equity awards in connection with his February 1, 2023 retirement.

GAAP to Non-GAAP Reconciliation of Second Quarter 2024 guidance:

GAAP and non-GAAP second quarter revenue guidance:

$665 million

to

$725 million

GAAP net income per diluted share

$

0.90

$

1.10

Exclude gain on divestiture

(0.36

)

(0.36

)

Exclude acquired intangible assets amortization

0.03

0.03

Non-GAAP tax adjustments

0.07

0.07

Non-GAAP net income per diluted share

$

0.64

$

0.84

For press releases and other information of interest to investors, please visit Teradyne's homepage at http://www.teradyne.com.

Contact:

Teradyne, Inc.

Traci Tsuchiguchi 978-370-2444

Vice President of Corporate Relations